We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Hot on the heels of the pharmaceutical sector inquiry in 2009 and the formal proceedings opened against Lundbeck, the European Commission revealed that it sent requests to a number of large pharmaceutical companies for copies of recent patent settlement agreements
On 12 July 2009, the European Commission (Commission) invited comments on commitments offered by the US microchip company by way of settlement following an investigation into claims of abuse of a dominant position
